- •Contents
- •Contributors
- •1 Introduction
- •2.1 Posterior Compartment
- •2.2 Anterior Compartment
- •2.3 Middle Compartment
- •2.4 Perineal Body
- •3 Compartments
- •3.1 Posterior Compartment
- •3.1.1 Connective Tissue Structures
- •3.1.2 Muscles
- •3.1.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2 Anterior Compartment
- •3.2.1 Connective Tissue Structures
- •3.2.2 Muscles
- •3.2.3 Reinterpreted Anatomy and Clinical Relevance
- •3.2.4 Important Vessels, Nerves, and Lymphatics of the Anterior Compartment
- •3.3 Middle Compartment
- •3.3.1 Connective Tissue Structures
- •3.3.2 Muscles
- •3.3.3 Reinterpreted Anatomy and Clinical Relevance
- •3.3.4 Important Vessels, Nerves, and Lymphatics of the Middle Compartment
- •4 Perineal Body
- •References
- •MR and CT Techniques
- •1 Introduction
- •2.1 Introduction
- •2.2.1 Spasmolytic Medication
- •2.3.2 Diffusion-Weighted Imaging
- •2.3.3 Dynamic Contrast Enhancement
- •3 CT Technique
- •3.1 Introduction
- •3.2 Technical Disadvantages
- •3.4 Oral and Rectal Contrast
- •References
- •Uterus: Normal Findings
- •1 Introduction
- •References
- •1 Clinical Background
- •1.1 Epidemiology
- •1.2 Clinical Presentation
- •1.3 Embryology
- •1.4 Pathology
- •2 Imaging
- •2.1 Technique
- •2.2.1 Class I Anomalies: Dysgenesis
- •2.2.2 Class II Anomalies: Unicornuate Uterus
- •2.2.3 Class III Anomalies: Uterus Didelphys
- •2.2.4 Class IV Anomalies: Bicornuate Uterus
- •2.2.5 Class V Anomalies: Septate Uterus
- •2.2.6 Class VI Anomalies: Arcuate Uterus
- •2.2.7 Class VII Anomalies
- •References
- •Benign Uterine Lesions
- •1 Background
- •1.1 Uterine Leiomyomas
- •1.1.1 Epidemiology
- •1.1.2 Pathogenesis
- •1.1.3 Histopathology
- •1.1.4 Clinical Presentation
- •1.1.5 Therapy
- •1.1.5.1 Indications
- •1.1.5.2 Medical Therapy and Ablation
- •1.1.5.3 Surgical Therapy
- •1.1.5.4 Uterine Artery Embolization (UAE)
- •1.1.5.5 Magnetic Resonance-Guided Focused Ultrasound
- •2 Adenomyosis of the Uterus
- •2.1 Epidemiology
- •2.2 Pathogenesis
- •2.3 Histopathology
- •2.4 Clinical Presentation
- •2.5 Therapy
- •3 Imaging
- •3.2 Magnetic Resonance Imaging
- •3.2.1 Magnetic Resonance Imaging: Technique
- •3.2.2 MR Appearance of Uterine Leiomyomas
- •3.2.3 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.4 Histologic Subtypes and Forms of Degeneration
- •3.2.5 Differential Diagnosis
- •3.2.6 MR Appearance of Uterine Adenomyosis
- •3.2.7 Locations, Growth Patterns, and Imaging Characteristics
- •3.2.8 Differential Diagnosis
- •3.3 Computed Tomography
- •3.3.1 CT Technique
- •3.3.2 CT Appearance of Uterine Leiomyoma and Adenomyosis
- •3.3.3 Atypical Appearances on CT and Differential Diagnosis
- •4.1 Indications
- •4.2 Technique
- •Bibliography
- •Cervical Cancer
- •1 Background
- •1.1 Epidemiology
- •1.2 Pathogenesis
- •1.3 Screening
- •1.4 HPV Vaccination
- •1.5 Clinical Presentation
- •1.6 Histopathology
- •1.7 Staging
- •1.8 Growth Patterns
- •1.9 Treatment
- •1.9.1 Treatment of Microinvasive Cervical Cancer
- •1.9.2 Treatment of Grossly Invasive Cervical Carcinoma (FIGO IB-IVA)
- •1.9.3 Treatment of Recurrent Disease
- •1.9.4 Treatment of Cervical Cancer During Pregnancy
- •1.10 Prognosis
- •2 Imaging
- •2.1 Indications
- •2.1.1 Role of CT and MRI
- •2.2 Imaging Technique
- •2.2.2 Dynamic MRI
- •2.2.3 Coil Technique
- •2.2.4 Vaginal Opacification
- •2.3 Staging
- •2.3.1 General MR Appearance
- •2.3.2 Rare Histologic Types
- •2.3.3 Tumor Size
- •2.3.4 Local Staging
- •2.3.4.1 Stage IA
- •2.3.4.2 Stage IB
- •2.3.4.3 Stage IIA
- •2.3.4.4 Stage IIB
- •2.3.4.5 Stage IIIA
- •2.3.4.6 Stage IIIB
- •2.3.4.7 Stage IVA
- •2.3.4.8 Stage IVB
- •2.3.5 Lymph Node Staging
- •2.3.6 Distant Metastases
- •2.4 Specific Diagnostic Queries
- •2.4.1 Preoperative Imaging
- •2.4.2 Imaging Before Radiotherapy
- •2.5 Follow-Up
- •2.5.1 Findings After Surgery
- •2.5.2 Findings After Chemotherapy
- •2.5.3 Findings After Radiotherapy
- •2.5.4 Recurrent Cervical Cancer
- •2.6.1 Ultrasound
- •2.7.1 Metastasis
- •2.7.2 Malignant Melanoma
- •2.7.3 Lymphoma
- •2.8 Benign Lesions of the Cervix
- •2.8.1 Nabothian Cyst
- •2.8.2 Leiomyoma
- •2.8.3 Polyps
- •2.8.4 Rare Benign Tumors
- •2.8.5 Cervicitis
- •2.8.6 Endometriosis
- •2.8.7 Ectopic Cervical Pregnancy
- •References
- •Endometrial Cancer
- •1.1 Epidemiology
- •1.2 Pathology and Risk Factors
- •1.3 Symptoms and Diagnosis
- •2 Endometrial Cancer Staging
- •2.1 MR Protocol for Staging Endometrial Carcinoma
- •2.2.1 Stage I Disease
- •2.2.2 Stage II Disease
- •2.2.3 Stage III Disease
- •2.2.4 Stage IV Disease
- •4 Therapeutic Approaches
- •4.1 Surgery
- •4.2 Adjuvant Treatment
- •4.3 Fertility-Sparing Treatment
- •5.1 Treatment of Recurrence
- •6 Prognosis
- •References
- •Uterine Sarcomas
- •1 Epidemiology
- •2 Pathology
- •2.1 Smooth Muscle Tumours
- •2.2 Endometrial Stromal Tumours
- •3 Clinical Background
- •4 Staging
- •5 Imaging
- •5.1 Leiomyosarcoma
- •5.2.3 Undifferentiated Uterine Sarcoma
- •5.3 Adenosarcoma
- •6 Prognosis and Treatment
- •References
- •1.1 Anatomical Relationships
- •1.4 Pelvic Fluid
- •2 Developmental Anomalies
- •2.1 Congenital Abnormalities
- •2.2 Ovarian Maldescent
- •3 Ovarian Transposition
- •References
- •1 Introduction
- •4 Benign Adnexal Lesions
- •4.1.1 Physiological Ovarian Cysts: Follicular and Corpus Luteum Cysts
- •4.1.1.1 Imaging Findings in Physiological Ovarian Cysts
- •4.1.1.2 Differential Diagnosis
- •4.1.2 Paraovarian Cysts
- •4.1.2.1 Imaging Findings
- •4.1.2.2 Differential Diagnosis
- •4.1.3 Peritoneal Inclusion Cysts
- •4.1.3.1 Imaging Findings
- •4.1.3.2 Differential Diagnosis
- •4.1.4 Theca Lutein Cysts
- •4.1.4.1 Imaging Findings
- •4.1.4.2 Differential Diagnosis
- •4.1.5 Polycystic Ovary Syndrome
- •4.1.5.1 Imaging Findings
- •4.1.5.2 Differential Diagnosis
- •4.2.1 Cystadenoma
- •4.2.1.1 Imaging Findings
- •4.2.1.2 Differential Diagnosis
- •4.2.2 Cystadenofibroma
- •4.2.2.1 Imaging Features
- •4.2.3 Mature Teratoma
- •4.2.3.1 Mature Cystic Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •4.2.3.2 Monodermal Teratoma
- •Imaging Findings
- •4.2.4 Benign Sex Cord-Stromal Tumors
- •4.2.4.1 Fibroma and Thecoma
- •Imaging Findings
- •4.2.4.2 Sclerosing Stromal Tumor
- •Imaging Findings
- •4.2.5 Brenner Tumors
- •4.2.5.1 Imaging Findings
- •4.2.5.2 Differential Diagnosis
- •5 Functioning Ovarian Tumors
- •References
- •1 Introduction
- •2.1 Context
- •2.2.2 Indications According to Simple Rules
- •References
- •CT and MRI in Ovarian Carcinoma
- •1 Introduction
- •2.1 Familial or Hereditary Ovarian Cancers
- •3 Screening for Ovarian Cancer
- •5 Tumor Markers
- •6 Clinical Presentation
- •7 Imaging of Ovarian Cancer
- •7.1.2 Peritoneal Carcinomatosis
- •7.1.3 Ascites
- •7.3 Staging of Ovarian Cancer
- •7.3.1 Staging by CT and MRI
- •Imaging Findings According to Tumor Stages
- •Value of Imaging
- •7.3.2 Prediction of Resectability
- •7.4 Tumor Types
- •7.4.1 Epithelial Ovarian Cancer
- •High-Grade Serous Ovarian Cancer
- •Low-Grade Serous Ovarian Cancer
- •Mucinous Epithelial Ovarian Cancer
- •Endometrioid Ovarian Carcinomas
- •Clear Cell Carcinomas
- •Imaging Findings of Epithelial Ovarian Cancers
- •Differential Diagnosis
- •Borderline Tumors
- •Imaging Findings
- •Differential Diagnosis
- •Recurrent Ovarian Cancer
- •Imaging Findings
- •Differential Diagnosis
- •Value of Imaging
- •Malignant Germ Cell Tumors
- •Dysgerminomas
- •Imaging Findings
- •Differential Diagnosis
- •Immature Teratomas
- •Imaging Findings
- •Malignant Transformation in Benign Teratoma
- •Imaging Findings
- •Differential Diagnosis
- •Sex-Cord Stromal Tumors
- •Granulosa Cell Tumors
- •Imaging Findings
- •Sertoli-Leydig Cell Tumor
- •Imaging Findings
- •Ovarian Lymphoma
- •Imaging Findings
- •Differential Diagnosis
- •7.4.3 Ovarian Metastases
- •Imaging Findings
- •Differential Diagnosis
- •7.5 Fallopian Tube Cancer
- •7.5.1 Imaging Findings
- •Differential Diagnosis
- •References
- •Endometriosis
- •1 Introduction
- •2.1 Sonography
- •3 MR Imaging Findings
- •References
- •Vagina and Vulva
- •1 Introduction
- •3.1 CT Appearance
- •3.2 MRI Protocol
- •3.3 MRI Appearance
- •4.1 Imperforate Hymen
- •4.2 Congenital Vaginal Septa
- •4.3 Vaginal Agenesis
- •5.1 Vaginal Cysts
- •5.1.1 Gardner Duct Cyst (Mesonephric Cyst)
- •5.1.2 Bartholin Gland Cyst
- •5.2.1 Vaginal Infections
- •5.2.1.1 Vulvar Infections
- •5.2.1.2 Vulvar Thrombophlebitis
- •5.3 Vulvar Trauma
- •5.4 Vaginal Fistula
- •5.5 Post-Radiation Changes
- •5.6 Benign Tumors
- •6.1 Vaginal Malignancies
- •6.1.1 Primary Vaginal Carcinoma
- •6.1.1.1 MRI Findings
- •6.1.1.2 Lymph Node Drainage
- •6.1.1.3 Recurrence and Complications
- •6.1.2 Non-squamous Cell Carcinomas of the Vagina
- •6.1.2.1 Adenocarcinoma
- •6.1.2.2 Melanoma
- •6.1.2.3 Sarcomas
- •6.1.2.4 Lymphoma
- •6.2 Vulvar Malignancies
- •6.2.1 Vulvar Carcinoma
- •6.2.2 Melanoma
- •6.2.3 Lymphoma
- •6.2.4 Aggressive Angiomyxoma of the Vulva
- •7 Vaginal Cuff Disease
- •7.1 MRI Findings
- •8 Foreign Bodies
- •References
- •Imaging of Lymph Nodes
- •1 Background
- •3 Technique
- •3.1.1 Intravenous Unspecific Contrast Agents
- •3.1.2 Intravenous Tissue-Specific Contrast Agents
- •References
- •1 Introduction
- •2.1.1 Imaging Findings
- •2.1.2 Differential Diagnosis
- •2.1.3 Value of Imaging
- •2.2 Pelvic Inflammatory
- •2.2.1 Imaging Findings
- •2.3 Hydropyosalpinx
- •2.3.1 Imaging Findings
- •2.3.2 Differential Diagnosis
- •2.4 Tubo-ovarian Abscess
- •2.4.1 Imaging Findings
- •2.4.2 Differential Diagnosis
- •2.4.3 Value of Imaging
- •2.5 Ovarian Torsion
- •2.5.1 Imaging Findings
- •2.5.2 Differential Diagnosis
- •2.5.3 Diagnostic Value
- •2.6 Ectopic Pregnancy
- •2.6.1 Imaging Findings
- •2.6.2 Differential Diagnosis
- •2.6.3 Value of Imaging
- •3.1 Pelvic Congestion Syndrome
- •3.1.1 Imaging Findings
- •3.1.2 Differential Diagnosis
- •3.1.3 Value of Imaging
- •3.2 Ovarian Vein Thrombosis
- •3.2.1 Imaging Findings
- •3.2.2 Differential Diagnosis
- •3.2.3 Value of Imaging
- •3.3 Appendicitis
- •3.3.1 Imaging Findings
- •3.3.2 Value of Imaging
- •3.4 Diverticulitis
- •3.4.1 Imaging Findings
- •3.4.2 Differential Diagnosis
- •3.4.3 Value of Imaging
- •3.5 Epiploic Appendagitis
- •3.5.1 Imaging Findings
- •3.5.2 Differential Diagnosis
- •3.5.3 Value of Imaging
- •3.6 Crohn’s Disease
- •3.6.1 Imaging Findings
- •3.6.2 Differential Diagnosis
- •3.6.3 Value of Imaging
- •3.7 Rectus Sheath Hematoma
- •3.7.1 Imaging Findings
- •3.7.2 Differential Diagnosis
- •3.7.3 Value of Imaging
- •References
- •MRI of the Pelvic Floor
- •1 Introduction
- •2 Imaging Techniques
- •3.1 Indications
- •3.2 Patient Preparation
- •3.3 Patient Instruction
- •3.4 Patient Positioning
- •3.5 Organ Opacification
- •3.6 Sequence Protocols
- •4 MR Image Analysis
- •4.1 Bony Pelvis
- •5 Typical Findings
- •5.1 Anterior Compartment
- •5.2 Middle Compartment
- •5.3 Posterior Compartment
- •5.4 Levator Ani Muscle
- •References
- •Evaluation of Infertility
- •1 Introduction
- •2 Imaging Techniques
- •2.1 Hysterosalpingography
- •2.1.1 Cycle Considerations
- •2.1.2 Technical Considerations
- •2.1.3 Side Effects and Complications
- •2.1.5 Pathological Findings
- •2.1.6 Limitations of HSG
- •2.2.1 Cycle Considerations
- •2.2.2 Technical Considerations
- •2.2.2.1 Normal and Abnormal Anatomy
- •2.2.3 Accuracy
- •2.2.4 Side Effects and Complications
- •2.2.5 Limitations of Sono-HSG
- •2.3 Magnetic Resonance Imaging
- •2.3.1 Indications
- •2.3.2 Technical Considerations
- •2.3.3 Limitations
- •3 Ovulatory Dysfunction
- •4 Pituitary Adenoma
- •5 Polycystic Ovarian Syndrome
- •7 Uterine Disorders
- •7.1 Müllerian Duct Anomalies
- •7.1.1 Class I: Hypoplasia or Agenesis
- •7.1.2 Class II: Unicornuate
- •7.1.3 Class III: Didelphys
- •7.1.4 Class IV: Bicornuate
- •7.1.5 Class V: Septate
- •7.1.6 Class VI: Arcuate
- •7.1.7 Class VII: Diethylstilbestrol Related
- •7.2 Adenomyosis
- •7.3 Leiomyoma
- •7.4 Endometriosis
- •References
- •MR Pelvimetry
- •1 Clinical Background
- •1.3.1 Diagnosis
- •1.3.2.1 Cephalopelvic Disproportion
- •1.3.4 Inadequate Progression of Labor due to Inefficient Contraction (“the Powers”)
- •2.2 Palpation of the Pelvis
- •3 MR Pelvimetry
- •3.2 MR Imaging Protocol
- •3.3 Image Analysis
- •3.4 Reference Values for MR Pelvimetry
- •5 Indications for Pelvimetry
- •References
- •MR Imaging of the Placenta
- •2 Imaging of the Placenta
- •3 MRI Protocol
- •4 Normal Appearance
- •4.1 Placenta Variants
- •5 Placenta Adhesive Disorders
- •6 Placenta Abruption
- •7 Solid Placental Masses
- •9 Future Directions
- •References
- •Erratum to: Endometrial Cancer
MR and CT Techniques
João Lopes Dias and Teresa Margarida Cunha
Contents
1 |
Introduction\ |
|
31 |
2 Magnetic Resonance Imaging\ |
|
32 |
|
2.1 |
Introduction\ |
|
32 |
2.2 Patient Preparation and Positioning\ |
|
32 |
|
2.3 |
Coils, Scan Planes, |
|
|
|
and General Protocols\ |
|
33 |
2.4 |
Gadolinium-Based Contrast Media\ |
|
37 |
3 |
CT Technique\ |
|
38 |
3.1 |
Introduction\ |
|
38 |
3.2 |
Technical Disadvantages\ |
|
40 |
3.3 Patient Preparation and Positioning\ |
|
40 |
|
3.4 Oral and Rectal Contrast\ |
|
40 |
|
3.5 Intravenous Iodine-Based |
|
|
|
|
Contrast Media\ |
|
41 |
Abstract
Magnetic resonance imaging (MRI) and computed tomography (CT) are routinely used in female pelvis imaging. MRI is primarily useful for locoregional characterization of benign and malignant diseases. CT is less accurate in locoregional evaluation, but remains useful in the follow-up of treated gynecological malignancies, as well as in the setting of emergency and in the guidance of biopsies. Although transabdominal and transvaginal ultrasonography (US) is not under the scope of this chapter, it remains the first-line imaging method for most gynecological conditions.
References\ |
42 |
J. Lopes Dias (*)
Centro Hospitalar de Lisboa Central, Lisbon, Portugal Hospital Lusíadas de Lisboa, Lisbon, Portugal
New Medical School, Lisbon, Portugal e-mail: joaolopesdias85@gmail.com
T.M. Cunha
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
e-mail: tmargarida@gmail.com
1\ Introduction
Magnetic resonance imaging (MRI) and computed tomography (CT) are routinely used in female pelvis imaging. MRI has a higher soft- tissue contrast and allows an accurate anatomic characterization of the pelvis as a whole, and a detailed depiction of the zonal anatomy. Thus, it is primarily useful for locoregional characterization of benign and malignant diseases. CT is less accurate in locoregional evaluation, but remains useful in the follow-up of treated gynecological malignancies, as well as in the setting of emergency (assessment of postsurgical complications and
Med Radiol Diagn Imaging (2017) |
31 |
DOI 10.1007/174_2017_51, © Springer International Publishing AG
Published Online: 03 May 2017
32 |
J. Lopes Dias and T.M. Cunha |
|
|
pelvic infectious diseases) and in the guidance of biopsies. Although transabdominal and transvaginal ultrasonography (US) is not under the scope of this chapter, it remains the first-line imaging method for most gynecological conditions.
This chapter aims to focus on some important, hands-on topics regarding MRI and CT techniques, trying not to exhaustively develop issues with isolated historical interest.
2\ Magnetic Resonance
Imaging
2.1\ Introduction
The introduction of modern phased-array coils with eight or more elements led to high signal-to- noise ratios (SNR) and consequently increased image quality. Additionally, pelvic examinations have become faster as turbo (TSE) and fast spin- echo (FSE) sequences have replaced conventional spin-echo (SE) sequences. Most MRI examinations are now performed at 1.5 and 3 Tesla (T) magnets. Despite significant improvement on SNR with higher field strength, 3 T magnets are more prone to magnetic susceptibility artifacts, which may be particularly prominent on diffusion-weighted imaging (DWI).
2.2\ Patient Preparation
and Positioning
Before performing an MR exam, the patient should be informed about its approximate duration as well as the necessity to use earplugs to protect against loud noises and to place a surface coil close to the skin. Moreover, all patients should be asked about contraindications and claustrophobia. Sedation may be required for those patients who would really benefit from the examination, but are unable to proceed due to claustrophobia. Any implanted device must be previously known and considered to be safe for the patient undergoing an MR procedure. Intrauterine devices (IUD) can be normally
scanned, and usually appear as a hypointense linear structure within the endometrial cavity on both T2-weighted images (T2WI).
Finally, patients should also be informed about the utility of intravenous (IV) contrast and spasmolytic agent administration, as well as their side effects (see next sections).
Whenever a pregnant woman is undergoing an MR exam, issues about the fetus development are raised. As a general rule, the risk-benefit ratio should be evaluated for every patient. Fetal deleterious effects have not been documented on 1.5 T magnets. However, some experts still recommend avoiding the exam in the first trimester unless the potential benefits compensate the hypothetical risks. Since most of the studies were performed on 1.5 T scanners, far less is known about potential effects on 3 T (Masselli et al. 2013; Ray et al. 2016).
Some authors advocate that patients should void about 1 h before the examination to ensure that the bladder is only moderately filled. A full bladder may hamper T2WI and give rise to motion artifacts due to patient discomfort.
A 4-h fast helps to reduce bowel peristalsis and is recommended in some centers when intravenous contrast administration is required. The administration of a fast-acting laxative enema to clean the bowel may also improve image quality.
It is uncommon to perform bowel preparation with diluted barium sulfate or other solutions as it increases preparation and imaging time and does not seem to bring significant advantages.
Vaginal tampon should be avoided. Vaginal opacification with ultrasound gel makes the evaluation of vaginal walls easy and may be recommended when studying vagina tumors and deep endometriosis. Moreover, rectal and/or vaginal opacification with ultrasound gel may be useful in dynamic pelvic floor and deep endometriosis studies (Beddy et al. 2012; Sala et al. 2013; Bazot et al. 2016).
Female pelvis imaging is usually performed with patients in supine position with the arms placed by their side. The placement of a bolster
MR and CT Techniques |
33 |
|
|
under the knees makes the examination more comfortable. Two important procedures are generally taken in order to decrease motion artifacts during abdominal and pelvic examinations: the use of a belt covering phased-array body coils, which restricts respiratory excursions, and the application of a spatial presaturation slab in a sagittal scout view, which is particularly useful in sequences without breathhold, because of its ability to reduce artifacts from the movement of the anterior abdominal wall (Sala et al. 2013; Forstner et al. 2016; Froehlich et al. 2009).
2.2.1\ Spasmolytic Medication
The administration of antispasmodic agents such as scopolamine N-butyl bromide (Buscopan®) or glucagon is indicated to reduce artifacts from small bowel and bladder motion. It is particularly useful in the assessment of peritoneal implants on both morphological and functional sequences, especially on DWI. The administration of intravenous Buscopan® (20–40 mg) immediately before the examination is the most consensual option. Longer examinations may justify a second identical dose, because IV Buscopan® action only lasts about 15 min. Intramuscular (IM) administration (20 mg) has an increased length of action (approximately 30–60 min). This anticholinergic drug should not be administered in patients who have demonstrated prior hypersensitivity to scopolamine N-butyl bromide, as well as in those with myasthenia gravis, narrow-angle glaucoma, megacolon, tachycardia, prostatic enlargement with urinary retention, paralytic ileus, or mechanical stenosis in the gastrointestinal tract. Data regarding contraindications during pregnancy is scarce; therefore Buscopan® is not recommended. Common undesirable effects may be accommodation disorders, tachycardia, dizziness, or dry mouth. If accommodation changes occur, patients should be advised not to drive.
When Buscopan® is contraindicated, glucagon (1 mg) can be administrated intravenously (Beddy et al. 2012; Sala et al. 2013; Bazot et al. 2016). In a study of Froehlich et al., glucagon
had more reliable onset of action and induced longer bowel paralysis when compared to scopolamine N-butyl bromide. Glucagon is contraindicated in patients with known hypersensitivity to the substance, as well as in those with known pheochromocytoma (due to the risk of stimulating catecholamine release). In patients with a known insulinoma, glucagon should be administered cautiously since its initial hyperglycemic effect may stimulate the release of insulin and cause subsequent hypoglycemia (Froehlich et al. 2009).
2.3\ Coils, Scan Planes,
and General Protocols
Female pelvic MRI is generally performed with a phased-array body coil with at least four elements. The introduction of modern coils improved SNR and allowed parallel imaging, thus reducing scan time on T1W and T2W conventional sequences. Intracavitary coils, either endovaginal or endorectal, have no current scientific support (Sala et al. 2013; Allen et al. 2014).
A general female pelvis protocol usually begins with a coronal localizer, which provides an anatomic overview of both lower abdomen and pelvis. It is helpful not only to guide pelvic sequences but also to exclude other conditions like hydronephrosis or renal malformations. Fast sequences like single-shot turbo or fast spin echo are generally used.
Specific protocols depend on the study target, but usually include an axial T1WI sequence and at least two T2WI sequences in different planes (Fig. 1). Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and DWI have become part of the standard imaging protocols for most of female pelvis MR examinations (Forstner et al. 2010, 2016; Allen et al. 2014; Sala et al. 2011).
Table 1 resumes a suitable general protocol for gynecological MRI. Specific parameters should always be adapted according to the magnet and coils available in each center.
34 |
J. Lopes Dias and T.M. Cunha |
|
|
a |
b |
c
Fig. 1 Examples of different orientations on MRI in distinct patients. Axial T1W image of the pelvis (a). Axial T2W image through the pelvis showing the uterus with an endometrial carcinoma associated with a polyp (b). Oblique sagittal according to the uterine axis T2W image showing the normal uterine zonal anatomy and a cervical cancer (c). Oblique coronal according to the long axis of
the uterus, parallel to the endometrial cavity (d). Axial oblique T2W image, perpendicular to the long axis of the cervix, for evaluation of parametrial invasion while staging a cervical cancer (e). Axial oblique TIW images after gadolinium with fat saturation, perpendicular to the long axis of the uterus, for local staging of an endometrial cancer (f)
MR and CT Techniques |
35 |
|
|
d
e
f
Fig. 1 (continued)